Daily FNArena News

The Chartist reports the recent bounce in the iron ore price might not simply represent a short term snap-back.

As three of Australia’s four big banks prepare to deliver earnings reports next week, brokers contemplate whether share prices have any reason to go either up or down.

Surfstitch has upgraded estimates for FY15, with substantial synergies emanating from the consolidation of European operations.

Michael Gable of Fairmont Equities suggests a pullback for Ramsay Healthcare is not an opportunity to be missed.

Sellers are being forced to lower prices in the face of a lack of spot market buying interest from utilities.

ResMed revealed strong growth in flow generator sales in the US in the March quarter but disappointed the market when it came to masks.

Eureka Group intends to become a significant owner operator of independent retirement units and Canaccord Genuity initiates coverage on the stock.

Nick Linton-Ffrost of Fifth Wave suggests the ASX200 is building for a break-out of its trading range, favouring the upside.

Australian Pharmaceutical Industries impressed brokers with its retail expansion but uncertainties prevail in its wholesale division.

Weekly update on recommendation, target price, and earnings forecast changes.